150 related articles for article (PubMed ID: 29122328)
41. Thyroid hormone replacement following lobectomy: Long-term institutional analysis 15 years after surgery.
Barranco H; Fazendin J; Lindeman B; Chen H; Ramonell KM
Surgery; 2023 Jan; 173(1):189-192. PubMed ID: 36202649
[TBL] [Abstract][Full Text] [Related]
42. Hypothyroidism after radiotherapy for primary thyroid lymphoma.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Kawamori J; Tanaka Y
Anticancer Res; 2014 Aug; 34(8):4427-31. PubMed ID: 25075081
[TBL] [Abstract][Full Text] [Related]
43. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
44. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
45. Analysis of an institutional protocol for thyroid lobectomy: Utility of routine intraoperative frozen section and expedited (overnight) pathology.
Berg RW; Yen TW; Evans DB; Hunt B; Quiroz FA; Wilson SD; Wang TS
Surgery; 2016 Feb; 159(2):512-7. PubMed ID: 26361834
[TBL] [Abstract][Full Text] [Related]
46. Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
Grigsby PW; Siegel BA; Bekker S; Clutter WE; Moley JF
J Nucl Med; 2004 Apr; 45(4):567-70. PubMed ID: 15073251
[TBL] [Abstract][Full Text] [Related]
47. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.
De Whalley P
Br J Gen Pract; 1995 Feb; 45(391):93-5. PubMed ID: 7702890
[TBL] [Abstract][Full Text] [Related]
48. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
49. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer.
Vaisman F; Shaha A; Fish S; Michael Tuttle R
Clin Endocrinol (Oxf); 2011 Jul; 75(1):112-9. PubMed ID: 21521273
[TBL] [Abstract][Full Text] [Related]
50. A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.
Lee EK; Kang YE; Park YJ; Koo BS; Chung KW; Ku EJ; Won HR; Yoo WS; Jeon E; Paek SH; Lee YS; Lim DM; Suh YJ; Park HK; Kim HJ; Kim BH; Kim M; Kim SW; Yi KH; Park SK; Jung EJ; Choi JY; Bae JS; Hong JH; Nam KH; Lee YK; Yu HW; Go S; Kang YM;
Endocrinol Metab (Seoul); 2021 Jun; 36(3):574-581. PubMed ID: 34034365
[TBL] [Abstract][Full Text] [Related]
51. Thyroid morphology and function after surgical treatment of thyroid diseases.
Mann B; Schmale P; Stremmel W
Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
[TBL] [Abstract][Full Text] [Related]
52. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment.
Maraka S; Mwangi R; McCoy RG; Yao X; Sangaralingham LR; Singh Ospina NM; O'Keeffe DT; De Ycaza AE; Rodriguez-Gutierrez R; Coddington CC; Stan MN; Brito JP; Montori VM
BMJ; 2017 Jan; 356():i6865. PubMed ID: 28122781
[TBL] [Abstract][Full Text] [Related]
53. Lobectomy in follicular thyroid neoplasms' treatment.
Antunes CM; Taveira-Gomes A
Int J Surg; 2013; 11(9):919-22. PubMed ID: 23863688
[TBL] [Abstract][Full Text] [Related]
54. Activation of brown adipose tissue in hypothyroidism.
Lapa C; Maya Y; Wagner M; Arias-Loza P; Werner RA; Herrmann K; Higuchi T
Ann Med; 2015; 47(7):538-45. PubMed ID: 26513396
[TBL] [Abstract][Full Text] [Related]
55. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.
Yip L; Wharry LI; Armstrong MJ; Silbermann A; McCoy KL; Stang MT; Ohori NP; LeBeau SO; Coyne C; Nikiforova MN; Bauman JE; Johnson JT; Tublin ME; Hodak SP; Nikiforov YE; Carty SE
Ann Surg; 2014 Jul; 260(1):163-8. PubMed ID: 24901361
[TBL] [Abstract][Full Text] [Related]
56. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
57. The role of thyrotropin suppression in patients with differentiated thyroid carcinoma.
Deasy J; Prichard RS; Evoy D; McDermott EW
Ir Med J; 2010; 103(7):202-5. PubMed ID: 20845598
[TBL] [Abstract][Full Text] [Related]
58. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
59. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism.
Loh JA; Wartofsky L; Jonklaas J; Burman KD
Thyroid; 2009 Mar; 19(3):269-75. PubMed ID: 19265498
[TBL] [Abstract][Full Text] [Related]
60. [The selection of surgical technique for differentiated thyroid carcinoma].
Zhou L
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 15(12):544-5. PubMed ID: 12541723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
